Pascal and Francis Bibliographic Databases

Help

Search results

Your search

kw.\*:("Tamoxifene")

Filter

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Language

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 5551

  • Page / 223
Export

Selection :

  • and

Triphenylethylenes: a new class of protein kinase C inhibitorsO'BRIAN, C. A; LISKAMP, R. M; SOLOMON, D. H et al.Journal of the National Cancer Institute. 1986, Vol 76, Num 6, pp 1243-1246, issn 0027-8874Article

Tamoxifen and 5-fluorouracil in breast cancer: cytotoxic synergism in vitro = Le tamoxifène et le 5-fluorouracile dans le cancer du sein: synergie cytotoxique in vitroBENZ, C; CADMAN, E; GWIN, J et al.Cancer research (Baltimore). 1983, Vol 43, Num 11, pp 5298-5303, issn 0008-5472Article

Adsorption of tamoxifen and 2-methyl derivatives under cell culture conditionsCHAMART, S; HANOCQ, M; LECLERCQ, G et al.International journal of pharmaceutics. 1993, Vol 99, Num 1, pp 59-65, issn 0378-5173Article

Characterization of the 4-hydroxytamoxifen (4-OHTAM) bound estrogen receptor of MCF-7 cells solubilized by micrococcal nucleaseGEIER, A; HAIMSOHN, M; BEERY, R et al.Journal of steroid biochemistry. 1985, Vol 23, pp 547-551, issn 0022-4731, 5AArticle

Response to toremifene (Fc-1157a) therapy in tamoxifen failed patients with breast cancer. Preliminary communicationEBBS, S. R; ROBERTS, J; BAUM, M et al.Journal of steroid biochemistry. 1990, Vol 36, Num 3, issn 0022-4731, p. 239Conference Paper

An evaluation of tamoxifen as a partial agonist by classical receptor theory ― an explanation of the dual action of tamoxifenMACNAB, M. W; TALLARIDA, R. J; JOSEPH, R et al.European journal of pharmacology. 1984, Vol 103, Num 3-4, pp 321-326, issn 0014-2999Article

Tamoxifen and 5-fluorouracil in breast cancer: modulation of cellular RNA = Le tamoxifène et le 5-fluorouracile dans le cancer du sein: modulation du RNA cellulaireBENZ, C; SANTOS, G; CADMAN, E et al.Cancer research (Baltimore). 1983, Vol 43, Num 11, pp 5304-5308, issn 0008-5472Article

The oestrogen antagonists, tamoxifen and FC-1157a, display oestrogen like effects on human lymphocyte functions in vitroPAAVONEN, T; ANDERSSON, L. C.Clinical and experimental immunology (Print). 1985, Vol 61, Num 2, pp 467-474, issn 0009-9104Article

TAMOXIFEN AS INITIAL SOLE TREATMENT OF LOCALISED BREAST CANCER IN ELDERLY WOMEN: A PILOT STUDYPREECE PE; WOOD RAB; MACKIE CR et al.1982; BR. MED. J.; ISSN 0007-1447; GBR; DA. 1982; VOL. 284; NO 6319; PP. 869-870; BIBL. 5 REF.Article

HYDROXYLATED METABOLITES OF TAMOXIFEN ARE FORMED IN VIVO AND BOUND TO ESTROGEN RECEPTOR IN TARGET TISSUESBORGNA JL; ROCHEFORT H.1981; J. BIOL. CHEM.; ISSN 0021-9258; USA; DA. 1981; VOL. 256; NO 2; PP. 859-868; BIBL. 33 REF.Article

Effects of tamoxifen and levonorgestrel treatment on carbon tetrachloride induced alterations in ratsKULCSAR, A; KULCSAR-GERGELY, J.Arzneimittel-Forschung. 1991, Vol 41, Num 12, pp 1298-1301, issn 0004-4172Article

Mechanism of inhibition of lipid peroxidation by tamoxifen and 4-hydroxytamoxifen introduced into liposomes. Similarity to cholesterol ang ergosterolWISEMAN, H; CANNON, M; ARNSTEIN, H. R. V et al.FEBS letters. 1990, Vol 274, Num 1-2, pp 107-110, issn 0014-5793Article

Treatment of oligozoospermia with tamoxifen (open and controlled studies)TOROK, L.Andrologia. 1985, Vol 17, Num 5, pp 497-501, issn 0303-4569Article

Über die Beeinflussung der Talgdrüsensekretion durch das Antiöstrogen Tamoxifen beim weiblichen und männlichen Goldhamster = Influence de l'antiœstrogène tamoxifène sur la sécrétion de la glande sébacée chez le hamster syrien femelle et mâle = The influence of the antiestrogen tamoxifen on the Sebaceous gland secretion in female and male golden syrian hamsterGLOOR, M; WIRTH, H; SCHLEIFER, K et al.H + G. Zeitschrift für Hautkrankheiten. 1983, Vol 58, Num 17, pp 1242-1247, issn 0301-0481Article

Tamoxifen decreases human prostate CPK concentrationGELLER, J; ALBERT, J. D; KIRSHNER, M et al.The Prostate. 1985, Vol 7, Num 3, pp 283-285, issn 0270-4137Article

Tamoxifen in the treatment of male breast carcinoma = Le tamoxifène dans le traitement du cancer du sein chez l'hommeRIBEIRO, G. G.Clinical radiology. 1983, Vol 34, Num 6, pp 625-628, issn 0009-9260Article

ANTIESTROGEN SPECIFIC, HIGH AFFINITY SATURABLE BINDING SITES IN RAT UTERINE CYTOSOLFAYE JC; LASSERRE B; BAYARD F et al.1980; BIOCHEM. BIOPHYS. RES. COMMUNIC.; USA; DA. 1980; VOL. 93; NO 4; PP. 1225-1231; BIBL. 13 REF.Article

Sensitivity and insensitivity of breast cancer to tamoxifenGIBSON, D. F. C; GOTTARDIS, M. M; JORDAN, V. C et al.Journal of steroid biochemistry and molecular biology. 1990, Vol 37, Num 6, pp 765-770, issn 0960-0760, 6 p.Conference Paper

Microbial transformation of tamoxifenEL-SHARKAWY, S; ABUL-HAJJ, Y. J.Pharmaceutical research. 1987, Vol 4, Num 4, pp 353-354, issn 0724-8741Article

Tamoxifen-Induced Ultraviolet, Recall DermatitisLEDET, Johnathan J; GRAFTON, Lee H.Journal of drugs in dermatology. 2009, Vol 8, Num 8, pp 761-762, issn 1545-9616, 2 p.Article

Double-blind controlled trial of tamoxifen therapy for mastalgiaFENTIMAN, I. S; CALEFFI, M; BRAME, K et al.Lancet (British edition). 1986, Num 8476, pp 287-288, issn 0140-6736Article

Investigating abnormal bleeding on HRT or tamoxifen: the role of ultrasonographyFERRAZZI, Enrico; LEONE, F. P. G.Baillière's best practice & research. Clinical obstetrics & gynaecology. 2004, Vol 18, Num 1, pp 145-156, issn 1521-6934, 12 p.Article

Antioestrogens in the management of hormone-dependent cancerLITHERLAND, S; JACKSON, I. M.Cancer treatment reviews. 1988, Vol 15, Num 3, pp 183-194, issn 0305-7372Article

Trans-4-hydroxytamoxifen concentration and metabolism after local percutaneous administration to human breastMAUVAIS-JARVIS, P; BAUDOT, N; CASTAIGNE, D et al.Cancer research (Baltimore). 1986, Vol 46, Num 3, pp 1521-1525, issn 0008-5472Article

Changes in bone mineral density during and after 3 years' use of tamoxifen or toremifeneTIITINEN, Aila; NIKANDER, Eini; HIETANEN, Päivi et al.Maturitas (Amsterdam). 2004, Vol 48, Num 3, pp 321-327, issn 0378-5122, 7 p.Article

  • Page / 223